Zydus Therapeutics New Drug Application (NDA) for Saroglitazar to Treat Primary Biliary Cholangitis (PBC) Granted Priority Review by the US FDA
PRNewsWire
·
2026-05-28
·
via The Tech Buzz - Press Releases
EPICS-III trial Phase 3 results demonstrated significant biochemical response; data to be presented as a late…
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。
